0
  • Business
  • Investing
  • Politics
  • Stocks
  • Latests news
The Investments Portal The Investments Portal
The Investments Portal The Investments Portal
The Investments Portal The Investments Portal
  • Business
  • Investing
  • Politics
  • Stocks
  • Latests news
The Investments Portal The Investments Portal
  • Business
  • Investing
  • Politics
  • Stocks
  • Latests news
The Investments Portal > Investing > RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0 Shares
Share on Facebook Share on Twitter Share on Pinterest Share on Email
admin June 4, 2025
Previous Article Operational Update
Next Article The Best Five Sectors, #21

You Might Also Enjoy

Silver Price Surges to US$36, Marking 13 Year High

June 6, 2025
READ MORE

Auto Industry Takes Hit as China’s Rare Earths Export Controls Impact Supply Chains

June 6, 2025
READ MORE

Retraction of Lo Herma Scoping Study Statements

June 6, 2025
READ MORE

Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow

June 6, 2025
READ MORE

      Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


      By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.


      • About us
      • Privacy Policy
      • Terms & Conditions

      Copyright © 2024 TheInvestmentsPortal.com. All Rights Reserved.

      Our website uses cookies to improve your experience. Learn more about: Cookie Policy

      Accept